搜索临床试验以:c.-32-13T>G mutation
总计3276个结果
-
Guangxi Medical University完全的C-KIT、PDGFRA和DOG1全基因序列筛选-测序法分析 | 研究GIST患者c-KIT、PDGFRA和DOG1不同基因突变的特征和变异
-
Chinese Lung Cancer Surgical GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Chinese PLA General Hospital; Peking... 和其他合作者未知
-
Gilead Sciences完全的
-
National Cancer Center, KoreaPfizer; Roche Pharma AG未知
-
ZhuGuangYingZhejiang Cancer Hospital; 307 Hospital of PLA; Fudan University; Cancer Institute and Hospital,... 和其他合作者未知
-
IRCCS Policlinico S. MatteoGlaxoSmithKline; University of Pavia; Azienda Ospedaliera di Padova; Azienda Ospedaliera di Perugia 和其他合作者完全的
-
Clinical Research Center for Solid Tumor, KoreaSeoul National University Hospital; Korean Cancer Study Group终止
-
Peking Union Medical College HospitalPeking University People's Hospital未知
-
Provitro GmbHCharite University, Berlin, Germany; AstraZeneca完全的
-
Taipei Medical University WanFang Hospital未知
-
Illumina, Inc.完全的Detection and Genotyping of Factor V and Factor II Point Mutations
-
SCRI Development Innovations, LLCGlaxoSmithKline完全的
-
Bristol-Myers Squibb完全的爱滋病毒感染美国, 阿根廷, 巴西, 危地马拉, 墨西哥, 秘鲁, 南非
-
Hillel Yaffe Medical CenterWeizmann Institute of Science未知
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)未知乳腺癌 | brca1突变携带者 | brca2突变携带者美国
-
Assistance Publique - Hôpitaux de Paris未知
-
Mayo ClinicGlaxoSmithKline完全的
-
Memorial Sloan Kettering Cancer CenterNew York University; Hadassah Medical Organization; New York Presbyterian Hospital; The New School...完全的
-
Assistance Publique - Hôpitaux de ParisNovartis; Association Rhumatisme et Travail完全的
-
SCRI Development Innovations, LLCGlaxoSmithKline; AstraZeneca; Aventis Pharmaceuticals完全的